Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of PCR- and HinfI restriction endonuclease-based methods for typing of Candida krusei isolates.

Literature DB >> 15583333

Comparison of PCR- and HinfI restriction endonuclease-based methods for typing of Candida krusei isolates.

Banu Sancak¹, John H Rex, Enuo Chen, Kieren Marr.

Abstract

We compared HinfI restriction endonuclease-based analysis of genomic DNA with a PCR-based method for molecular typing of 90 Candida krusei isolates from 17 geographically related patients. Strain groupings by these methods were the same for 89 of 90 isolates. Ten of 17 patients were infected with related strains of C. krusei.

Entities: Species

Mesh：

Substances：

Year: 2004 PMID： 15583333 PMCID： PMC535297 DOI： 10.1128/JCM.42.12.5889-5891.2004

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

13 in total

1. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole.

Authors: M Akova; H E Akalin; O Uzun; D Gür
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-07 Impact factor: 3.267

2. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.

Authors: J Abbas; G P Bodey; H A Hanna; M Mardani; E Girgawy; D Abi-Said; E Whimbey; R Hachem; I Raad
Journal: Arch Intern Med Date: 2000-09-25

3. Application of DNA typing methods to epidemiology and taxonomy of Candida species.

Authors: S Scherer; D A Stevens
Journal: J Clin Microbiol Date: 1987-04 Impact factor: 5.948

4. Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.

Authors: P Boerlin; F Boerlin-Petzold; J Goudet; C Durussel; J L Pagani; J P Chave; J Bille
Journal: J Clin Microbiol Date: 1996-05 Impact factor: 5.948

5. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors: J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal: N Engl J Med Date: 1991-10-31 Impact factor: 91.245

6. Strain variation among and antifungal susceptibilities of isolates of Candida krusei.

Authors: Y F Berrouane; R J Hollis; M A Pfaller
Journal: J Clin Microbiol Date: 1996-07 Impact factor: 5.948

7. Rapid identification and fingerprinting of Candida krusei by PCR-based amplification of the species-specific repetitive polymorphic sequence CKRS-1.

Authors: A Carlotti; F Chaib; A Couble; N Bourgeois; V Blanchard; J Villard
Journal: J Clin Microbiol Date: 1997-06 Impact factor: 5.948

Comparison of PCR- and HinfI restriction endonuclease-based methods for typing of Candida krusei isolates.

1. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole.

2. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.

3. Application of DNA typing methods to epidemiology and taxonomy of Candida species.

4. Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.

5. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

6. Strain variation among and antifungal susceptibilities of isolates of Candida krusei.

7. Rapid identification and fingerprinting of Candida krusei by PCR-based amplification of the species-specific repetitive polymorphic sequence CKRS-1.

8. DNA fingerprinting patterns of Candida species using HinfI endonuclease.

Review 9. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.

10. Increased incidence of fungemia caused by Candida krusei.

1. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.

2. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.